Cargando…
FGFR1 inhibition in lung squamous cell carcinoma: questions and controversies
Although the incidence of lung cancer has decreased due to the reduction of tobacco use, lung cancer remains the leading cause of cancer-related death. Lung squamous cell carcinoma represents 30% of lung cancers and only recently have possible drug-targetable mutations been identified in this diseas...
Autores principales: | Weeden, CE, Solomon, B, Asselin-Labat, M-L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979434/ https://www.ncbi.nlm.nih.gov/pubmed/27551478 http://dx.doi.org/10.1038/cddiscovery.2015.49 |
Ejemplares similares
-
Holding our breath: the promise of tissue-resident memory T cells in lung cancer
por: Marceaux, Claire, et al.
Publicado: (2021) -
Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer
por: Malchers, Florian, et al.
Publicado: (2023) -
Questions & Controversies
por: Silke, J
Publicado: (2015) -
Expression and clinical significance of FGFR1 and FGFR2 in laryngeal squamous cell carcinoma
por: Hu, Mengdie, et al.
Publicado: (2022) -
FGFR3-TACC3 is an oncogenic fusion protein in respiratory
epithelium
por: Best, Sarah A., et al.
Publicado: (2018)